Related Experiment Video
Updated: Feb 21, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
Cystic fibrosis swine fail to secrete airway surface liquid in response to inhalation of pathogens
Xiaojie Luan1, George Belev2, Julian S Tam3
1Department of Physiology, University of Saskatchewan, Health Science Building, Room 2D01, 107 Wiggins Road, Saskatoon, SK, Canada, S7N 5E5.
Abstract:
Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) channel, which can result in chronic lung disease. The sequence of events leading to lung disease is not fully understood but recent data show that the critical pathogenic event is the loss of the ability to clear bacteria due to abnormal airway surface liquid secretion (ASL). However, whether the inhalation of bacteria triggers ASL secretion and whether this is abnormal in cystic fibrosis has never been tested. Here we show, using a novel synchrotron-based in vivo imaging technique, that wild-type pigs display both a basal and a Toll-like receptor-mediated ASL secretory response to the inhalation of cystic fibrosis relevant bacteria. Both mechanisms fail in CFTR-/- swine, suggesting that cystic fibrosis airways do not respond to inhaled pathogens, thus favoring infection and inflammation that may eventually lead to tissue remodeling and respiratory disease.Cystic fibrosis is caused by mutations in the CFTR chloride channel, leading to reduced airway surface liquid secretion. Here the authors show that exposure to bacteria triggers secretion in wild-type but not in pig models of cystic fibrosis, suggesting an impaired response to pathogens contributes to infection.
Insights
Cystic fibrosis (CF) airways fail to secrete liquid when exposed to bacteria. This impaired response in CFTR-mutated pigs suggests a mechanism for chronic lung infections in cystic fibrosis.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Genetics
Background:
- Cystic fibrosis (CF) results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, leading to chronic lung disease.
- Impaired airway surface liquid (ASL) secretion and bacterial clearance are key pathogenic events in CF lung disease.
- It remains unclear if inhaled bacteria trigger ASL secretion and if this response is abnormal in CF.
Purpose of the Study:
- To investigate whether inhaled bacteria stimulate ASL secretion.
- To determine if this response is impaired in cystic fibrosis models.
Main Methods:
- Utilized a novel synchrotron-based in vivo imaging technique.
- Exposed wild-type and CFTR-deficient (CFTR-/-) pigs to cystic fibrosis-relevant bacteria.
Main Results:
- Wild-type pigs demonstrated both basal and Toll-like receptor-mediated ASL secretion in response to inhaled bacteria.
- CFTR-/- swine exhibited a complete failure of both basal and stimulated ASL secretion.
- This suggests CF airways do not adequately respond to inhaled pathogens.
Conclusions:
- The study reveals a critical defect in the airway's response to inhaled bacteria in cystic fibrosis.
- This impaired pathogen sensing and ASL secretion likely contributes to increased infection and inflammation in CF lungs.
- The findings highlight a potential therapeutic target for preventing CF lung disease progression.
More Related Videos
10:18Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
Published on: June 13, 2019
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Breathing
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation